Connection

Evangelos Terpos to Retrospective Studies

This is a "connection" page, showing publications Evangelos Terpos has written about Retrospective Studies.
Connection Strength

0.050
  1. Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival. Ann Hematol. 2018 Sep; 97(9):1671-1682.
    View in: PubMed
    Score: 0.019
  2. Increased expression of platelet derived growth factor receptor ß on trephine biopsies correlates with advanced myeloma. J BUON. 2017 Jul-Aug; 22(4):1032-1037.
    View in: PubMed
    Score: 0.018
  3. Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis. Amyloid. 2018 Dec; 25(4):234-241.
    View in: PubMed
    Score: 0.005
  4. Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group. Blood Cancer J. 2018 03 09; 8(3):31.
    View in: PubMed
    Score: 0.005
  5. Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis. Leuk Lymphoma. 2006 Aug; 47(8):1553-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.